Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dr. Martens Plc ( (GB:DOCS) ) just unveiled an update.
Dr. Martens plc has confirmed that its issued ordinary share capital stands at 967,928,331 shares, each carrying one voting right and with none held in treasury. This figure sets the official denominator for investors when calculating whether they must disclose new or changed shareholdings under UK financial transparency rules, supporting clearer oversight of ownership in the listed footwear group.
The most recent analyst rating on (GB:DOCS) stock is a Hold with a £0.85 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.
Spark’s Take on DOCS Stock
According to Spark, TipRanks’ AI Analyst, DOCS is a Neutral.
Dr. Martens Plc’s overall stock score reflects a mix of financial challenges and strategic progress. The most significant factor is the company’s financial performance, which is hindered by declining revenue and profitability. Technical analysis indicates bearish momentum, while valuation suggests the stock is overvalued. Positive corporate events and earnings call insights provide some optimism, but challenges remain.
To see Spark’s full report on DOCS stock, click here.
More about Dr. Martens Plc
Dr. Martens plc is an iconic British footwear manufacturer best known for its 1460 boot and other “Docs” styles that evolved from workwear into global fashion staples. Headquartered in England and operating in more than 60 countries, the FTSE 250-listed group sells through retail, ecommerce and wholesale channels, offering boots, shoes, sandals, kids’ lines and accessories that emphasise craftsmanship, heritage and distinctive design.
Average Trading Volume: 1,366,593
Technical Sentiment Signal: Sell
Current Market Cap: £589.7M
For an in-depth examination of DOCS stock, go to TipRanks’ Overview page.

